These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 29273624)

  • 21. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.
    Beltrán-Anaya FO; Romero-Córdoba S; Rebollar-Vega R; Arrieta O; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Riuz L; Jiménez-Morales S; Cedro-Tanda A; Ríos-Romero M; Reyes-Grajeda JP; Tagliabue E; Iorio MV; Hidalgo-Miranda A
    Mol Oncol; 2019 Apr; 13(4):909-927. PubMed ID: 30648789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.
    Hamdan FH; Johnsen SA
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12343-E12352. PubMed ID: 30541891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in molecular features of triple-negative breast cancers based on the age at diagnosis.
    Gulbahce HE; Bernard PS; Weltzien EK; Factor RE; Kushi LH; Caan BJ; Sweeney C
    Cancer; 2018 Dec; 124(24):4676-4684. PubMed ID: 30311638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of sequence determinants of enhancer function using natural genetic variation.
    Yang MG; Ling E; Cowley CJ; Greenberg ME; Vierbuchen T
    Elife; 2022 Aug; 11():. PubMed ID: 36043696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancer-driven gene regulatory networks inference from single-cell RNA-seq and ATAC-seq data.
    Li Y; Ma A; Wang Y; Guo Q; Wang C; Fu H; Liu B; Ma Q
    Brief Bioinform; 2024 Jul; 25(5):. PubMed ID: 39082647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic transcription factors instruct promoter-enhancer hubs in individual triple negative breast cancer cells.
    Zhao J; Zhou Y; Tzelepis I; Burget NG; Shi J; Faryabi RB
    Sci Adv; 2024 Aug; 10(32):eadl4043. PubMed ID: 39110799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
    Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-omics analysis reveals the functional transcription and potential translation of enhancers.
    Wu Y; Yang Y; Gu H; Tao B; Zhang E; Wei J; Wang Z; Liu A; Sun R; Chen M; Fan Y; Mao R
    Int J Cancer; 2020 Oct; 147(8):2210-2224. PubMed ID: 32573785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes.
    Xi Y; Shi J; Li W; Tanaka K; Allton KL; Richardson D; Li J; Franco HL; Nagari A; Malladi VS; Coletta LD; Simper MS; Keyomarsi K; Shen J; Bedford MT; Shi X; Barton MC; Kraus WL; Li W; Dent SYR
    BMC Genomics; 2018 Feb; 19(1):150. PubMed ID: 29458327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart.
    He A; Kong SW; Ma Q; Pu WT
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5632-7. PubMed ID: 21415370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer.
    Hariprakash JM; Salviato E; La Mastra F; Sebestyén E; Tagliaferri I; Silva RS; Lucini F; Farina L; Cinquanta M; Rancati I; Riboni M; Minardi SP; Roz L; Gorini F; Lanzuolo C; Casola S; Ferrari F
    Cancer Res; 2024 Jan; 84(1):133-153. PubMed ID: 37855660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.
    Luan H; Mohapatra B; Bielecki TA; Mushtaq I; Mirza S; Jennings TA; Clubb RJ; An W; Ahmed D; El-Ansari R; Storck MD; Mishra NK; Guda C; Sheinin YM; Meza JL; Raja S; Rakha EA; Band V; Band H
    Cancer Res; 2018 May; 78(10):2524-2535. PubMed ID: 29510992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.
    Chen L; Huang M; Plummer J; Pan J; Jiang YY; Yang Q; Silva TC; Gull N; Chen S; Ding LW; An O; Yang H; Cheng Y; Said JW; Doan N; Dinjens WN; Waters KM; Tuli R; Gayther SA; Klempner SJ; Berman BP; Meltzer SJ; Lin DC; Koeffler HP
    Gut; 2020 Apr; 69(4):630-640. PubMed ID: 31409603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors.
    Wang C; Zhang L; Ke L; Ding W; Jiang S; Li D; Narita Y; Hou I; Liang J; Li S; Xiao H; Gottwein E; Kaye KM; Teng M; Zhao B
    Nat Commun; 2020 Dec; 11(1):6318. PubMed ID: 33298918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total Functional Score of Enhancer Elements Identifies Lineage-Specific Enhancers That Drive Differentiation of Pancreatic Cells.
    Malladi VS; Nagari A; Franco HL; Kraus WL
    Bioinform Biol Insights; 2020; 14():1177932220938063. PubMed ID: 32655276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Analysis of p53-Regulated Enhancers in Hepatic Carcinoma.
    Zhang Y; Qian M; Tang F; Huang Q; Wang W; Li Y; Li Z; Li B; Qiu Z; Yue J; Guo Z
    Front Bioeng Biotechnol; 2020; 8():668. PubMed ID: 32695760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.